CREW ANDREW P.,DONG HANQING,FERRARO CATERINA,SHERMAN DAN,SIU KAM W.
申请号：
PL11794899
公开号：
PL2646448T3
申请日:
2011.11.29
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.
